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KAWASAKI SYNDROME IN TEXAS

ABSTRACT
The purpose of this study was to examine the hospitalization rates of Kawasaki Syndrome
(KS) among children living in Texas to isolate clusters, identify demographic disparities, and
suggest possible causative factors. A retrospective cross-sectional study design identified 330
KS cases from 2,818,460 hospital discharges extracted from the 2004 Texas hospital discharge
database. Categorical variables and proportions were analyzed using Pearson Chi-Square
analysis for bivariate comparison of hospitalization rates and other demographic and
geographic variables. Overall, the majority of the cases (61.5%) fell within the 1 to 4 year age
category, representing the highest hospitalization rate at 14.3 per 100,000 children. Almost
75% of the KS population was less than five years old with a hospitalization rate that was
about eight times higher than all other children ( p<0.05). The KS diagnosis occurred for only
49.4% of all KS cases upon admission. About 52% of Non Hispanic Blacks (NHB) used the
ER as their main source of admission and Medicaid was the main payment source for
Hispanics (67.2%). High density clusters were identified in major metropolitan areas, with the
Dallas-Fort Worth and Houston areas representing 26.6% and 18.8% of all of the state’s 2004
KS cases, respectively. Although the overall hospitalization rate of KS in Texas is consistent
with national rates, significant high risk areas exist, both geographically and demographically.
The highest hospitalization rate of KS was found among Asian and Pacific Islanders and NHB
children which suggest genetic predisposition for the first group and reflect difficulties with
access to healthcare for NHB. With an initial diagnosis rate of less than 50%, educating
physicians and other healthcare providers to recognize of the symptoms of KS is imperative,

particularly for ER and primary care providers. Support is recommended mandating KS as
reportable condition by hospitals.
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INTRODUCTION
Kawasaki Syndrome (KS) is a disease that involves the skin, mouth, and lymph nodes
typically affecting children under five years of age (American Heart Association [AHA] 2001;
Centers for Disease Control [CDC] 2007;Kawasaki Disease Foundation 2007) . It is currently
one of the leading causes of acquired cardiovascular disease in children in the U.S. (AHA
2001; CDC 2007; Kawasaki Disease Foundation 2007). KS was first described in Japan by
Kawasaki in 1967 (Kawasaki, Kosaki, Okawa, Shigematsu, and Yanagawa 1974). The first
cases reported beyond Japan’s islands occurred in Hawaii and reported in 1976 (Melish,
Hicks, and Larson 1976).
We defined KS according to Centers for Disease Control (CDC 2007) and American
Heart Association (AHA 2001) criteria. These diagnostic criteria include presence of a high
fever for four or five days duration along with four or more additional symptoms. The
additional clinical signs include rash, red eyes, red swollen and cracked lips, "strawberry"
tongue, swollen hands and feet, swollen lymph nodes, or redness of the palms of the hands and
of the soles of the feet (AHA 2001).For epidemiologic surveillance, CDC (2007) defines KS
as a patient demonstrating fever for five or more days or until the date of administration of
intravenous immunoglobulin, if given before day five of fever, and the presence of at least
four of the clinical signs of rash, cervical lymphadenopathy at least 1.5 cm in diameter,
bilateral conjunctival injection, oral mucosal changes, and peripheral extremity changes.

When the fever is misinterpreted and the rash is overlooked by physicians, KS can
progress untreated. Cardiac involvement of an untreated KS child can have serious and
sometimes fatal consequences (Newburger et al. 2004). The main complication for those
surviving KS is Coronary Artery Aneurysms (CAA); (Freeman and Shulman 2006). CAA has
an 8.6% incidence in patients meeting the diagnostic criteria for KS and a 25% incidence in
those not receiving a timely KS diagnosis (Freeman and Shulman 2006).
Treatment within ten days after onset of fever is essential to decrease the risk of heart
problems. With appropriate detection and treatment, the incidence of CAA can be reduced to
from 1% to 5% (Gersony 1991). Treating KS consists of administering intravenous
immunoglobulin (IVG) for 8 to 12 hours within ten days of fever onset. High doses of aspirin
are administered until the fever subsides. A decreased dosage of aspirin continues for at least
two months to reduce spontaneous coronary thrombosis (Rauch 1987).
The etiology of KS is unknown. Possible causes are prior respiratory disease, exposure
to carpet cleaning chemicals, use of humidifiers, or living in close proximity to bodies of
water (Rauch et al. 1988; Rauch et al. 1991; Lloyd et al. 2001; Kawasaki Disease Foundation
2007). Other researchers strongly have suggested an infectious cause (Rauch 1987; Gersony
1991; Belay et al. 2005 ;). Several microbial agents, such as rickettsiae, propionibacterium
acnes, klebsiella pneumoniae, ehrlichia sp, parainfluenza virus types 2 and 3, Epstein- Barr
virus, rotavirus, and many others, have been studied in KS patients (Rauch et al. 1991; Chua
2001; Belay et al. 2005; Dominguez et al. 2006). Although multiple infectious agents and
toxins have been implicated in the etiology of the disease, none have been confirmed to cause
KS (Chang 2003; Burns 2007). With the etiology of KS unknown after 40 years of intense
research (Kao 2005), no specific laboratory test, such as blood test or throat culture, has been

developed to diagnose KS and atypical cases (CDC 2007). Delayed diagnosis and treatment
have been unavoidable. Furthermore, diagnosis is complicated by KS’ symptoms and signs
being present in other illnesses (Gersony 1991).
Estimation of national and state incidence of KS has been difficult, because case
reporting to the CDC has been sporadic (Kao 2005). Tracking has been left to state agencies
(Holman et al. 2003). As is the case with any large passive surveillance system, only a fraction
of the total cases have been reported (Rauch et al. 1991).
Outbreaks of KS have been reported, but active reporting is only performed in 11
states (Holman et al. 2003). Instead, studies using hospital discharge data have been used for
KS surveillance and reporting (Chang 2003). In outbreak investigations conducted in Texas
and North Carolina in 1984, and in Colorado in 1986, the CDC found KS patients’ homes
tended to be less than 200 yards from the nearest body of water, usually a creek or drainage
ditch (Rauch et al. 1988). Additionally, Chang found the overwhelming majority of children
with KS (>96%) are hospitalized (Burns et al. 1984). In the U.S. in 2005, the estimated
number of new KS cases totaled 5,000, and the attack rate for children under five years of age
was 20 to 25 cases per 100, 000 children (Chang 2003). In Texas, the current incidence of KS
and CAA resulting from KS is not known, because KS is not actively tracked by the Texas
Department of State Health Services (Su 2007).
Kawasaki Syndrome is most common among children of Japanese and Korean descent
but can affect all ethnic and racial groups (Belay et al. 2006). Evidence indicates a higher rate
of KS among Asian Americans and Pacific Islanders (32.5 cases per 100,000 children less
than five years old). The rates are less for Non-Hispanic Blacks (16.9 cases per 100,000
children less than five years old) and Hispanics (11.1 cases per 100,000 children less than five

years old). The lowest rate was among Non-Hispanic Whites (9.1 cases per 100,000 children
less than five years old (Newburger et al. 2004). For the Hispanic group, treatment for the
CAA outcome of KS has been reported as being delayed due to the group’s lack of access to
healthcare (Belay et al. 2006).
The purpose of the present study was to describe the hospitalization rate of KS in
Texas children using the Texas hospital discharge database and to describe the demographic
characteristics of Texas children with KS.

METHODOLOGY
This retrospective cross-sectional study employed data from a public domain data file
maintained by the Texas Health Information Council (THCIC), the Texas warehouse of
hospital discharge data (Texas Department of Health Services 2004). Data were extracted
from a base population of 2,818,460 hospital discharges obtained from the 2004 public
THCIC dataset. Cases with KS were identified using the International Classification of
Diseases, 9th revision Clinical Modification (ICD-9 CM) code: 446.1 for Kawasaki Syndrome
or mucocutaneous lymph node syndrome present in the principal discharge diagnosis and all
other discharge diagnoses (U.S. Department of Health and Human Services 1988; Texas State
Data Center 2005).

Characteristics of Interest
Age, gender, race/ethnicity, risk mortality, illness severity, admitting diagnosis, source
of admission, and payment source were investigated. The six age categories were,

respectively, less than 1 year, 1 to 4 years, 5 to 9 years, 10 to 14 years, 15 to 17 years, and 18
years or older. For specific comparisons, these categories were dichotomized into less than
five years old and equal or greater than five years old. Race and ethnicity were restructured to
four major groups of Non-Hispanic Whites (NHW), Non-Hispanic Blacks (NHB), Hispanics,
and Asians and Pacific Islanders (API). Other admitting diagnosis in KS patients included:
fever (ICD9 code 780.6), and rash (ICD9 code 782.1). All other admitting diagnoses were
combined and placed in the category labeled as Other with their frequencies less than five
percent. Principal diagnosis was identified in the same way in terms of ICD 9th CM.
Admission sources included Emergency Room (ER), physician referral, transfer from other
hospital, or other. Risk of mortality score and severity of illness was assigned from All Patient
Refined Diagnosis Related Group (APR-DRG) from the 3M APR-DRG Grouper, version 20,
indicating the likelihood of dying and the extent of physiologic decompensation. The four
insurance status groups were private insurance, Medicaid, uninsured (self pay or indigent), and
Other-labeled insurance. The Texas counties with more than four percent of the state’s KS
admissions are reported in Table 3.

Data Analysis
Categorical variables and proportions were analyzed using Pearson Chi -Square
analysis for bivariate comparison by ethnicity, gender, and other variables. Hospitalization
rates (Chang 2003) were calculated with the number of cases as numerator and the population
estimate for 2004 by age as denominator (proxy for incidence rate). The population estimate
for 2004 by age and county were obtained from the Texas State Data Center and Office of the
State Demographer (Texas State Data Center 2005). A p-value of less than 0.05 was

considered statistically significant. Statistical analyses were performed using SPSS version 15.
For this study’s protocol, appropriate approvals related to the protection of human subjects
were sought and received from the Institutional Review Board of the University of North
Texas Health Science Center at Fort Worth.
RESULTS
Patient Characteristics
The discharge diagnosis consistent with KS was identified for a total of 330 cases.
Sixty percent were male, 5.7 % API, 37.9% Hispanic, 31.9% NHW and 17.6% NHB. The
stratified age distribution for the 330 KS cases is shown in Table 1. The majority of the cases
at 61.5% fell in the 1 to 4 years of age category. This age category represented the highest
hospitalization rate at 14.3 per 100,000 children. Almost 75% of the KS population was less
than five years old, and its hospitalization rate was about eight times higher than greater or
equal than five years old (13.8 per 100,000 children versus 1.8 per 100,000 children,
respectively), which was significant (p<0.05, Table1). For the category with age less than one
year old, the highest hospitalization rate for API was 44.9 per 100,000, while NHW displayed
8.8 per 100,000 children and NHB and Hispanics exhibited 14.7 and 12.5 per 100,000
children, respectively (p< 0.05).
As seen in Table 1 with hospitalization rates by race/ethnicity for those less than five
years old, the highest hospitalization rate occurred for API and NHB with 29.8 and 18.4 per
100,000 children respectively, as compared to NHW representing 9.7 per 100,000 children (p<
0.05). In both age groups, NHB presented significantly higher hospitalization rates than NHW,
the control group. In comparing age group by gender, males’ less than one year old category,
were diagnosed with KS at twice as often as females of the same age and demonstrated

significant higher hospitalization rates (p< 0.05), (Table 1). Anecdotally, only two cases of KS
with CAA were reported.
Table 1 about here
Table 2 presents the results of risk mortality, illness severity, admitting diagnosis,
source of admission, and payment source by ethnicity for the 330 KS cases. Regarding
admitting diagnoses, KS was diagnosed as such only 49.4% of the time upon admission to the
hospital and only 22.2% in the API group. Fever was the second most frequent admitting
diagnosis at 32.4% and occurred at a 72.2% rate for the API group. Rash and non specific
eruption were present in 5.8% of the cases and was higher for NHW (9.5%; Table 2). There
were 41cases with all other admitting diagnoses constituting 12% of all cases. The variable,
Physician referral was the source of admission for 48.8% of the cases followed by ER
admission for 39.7%. Non Hispanic blacks’ use of the ER was 51.7% as compared to 33.3%
for NHW. Non Hispanic blacks had a much lower private insurance rate (36.2 %) than NHW
(53.3%; Table 2). Hispanics used Medicaid as their primary payment source (67.2%) more
than three times as often as NHW (20 %).

Table 2 about here
Table 3 depicts the Texas counties representing at least 4% of the 2004 KS cases.
Collin County had the highest incidence rate of KS in the Texas Counties with a rate of 29.0
per 100,000 for children less than five years old and 30.6 per 100,000 for children of age less
than 1 year old. Travis County presented a high hospitalization rate with 42 per 100,000
children of age less than one year old. Harris County, which includes Houston, reported the
most KS cases in the state; Dallas County reported the second highest number of cases. The

two counties’ hospitalization rates were 15.7 and 16.1 per 100,000 cases, respectively, in
children of age less than five years old. Travis County, home to Austin, and Bexar County,
home to San Antonio, showed similar frequencies of KS cases but hospitalization rates of 17.6
and 11.7 per 100,000 children less than five years old, respectively (Table 3). Three of the
highest hospitalization rates by county (Collin, Dallas, and Tarrant) occurred for the Dallas
Fort Worth Metroplex (DFW) area, representing 21.5% of the state’s 2004 KS cases. By
including the remaining DFW counties, all of DFW represented 26.6% of the state’s 2004 KS
cases. The counties not listed in Table 3, because their frequencies less than 4%, were
combined and placed in the category labeled as other. Consequently, 147 KS cases in the
other-labeled counties represented 44.6% of the state’s 2004 KS cases.
Table 3 about here

DISCUSSION
All ethnic/racial groups were affected by KS in the study sample, with the highest
hospitalization within API for the less than five years old group at 29.8 per 100,000 children.
This figure is close to the 32.5 per 100,000 children reported by Newburger et al. (2004) and
to other academic evidence indicating a higher hospitalization rate of KS among API children
(Burns 2007; Burns et al. 1984; Chang 2003; Gersony 1991; Holman et al. 2003; Kao
2005).We concur with the former study for all other racial/ethnic patients of age less than five
years old, based on our finding of a higher rate of 18.4 per 100,000 children for NHB and of a
lower rate for Hispanic and NHW of 12.6 and 9.7 per 100,000 children, respectively. We find
this pattern to be similar to that of children of age less than one year old. However, API’s KS
hospitalization rate was 44.9 per 100,000 children. For children of all ethnicities and races
with age less than five years old, the estimated 2004 KS hospitalization rate was 13.8 per

100,000 children. This estimated KS rate was consistent with KS hospitalization rates reported
in previous studies within the US (range of 9–19 per 100,000 children); Burns 2007; CDC
2007; Chang 2003). Male children were more likely than female children in both of the age
categories of less than 1 year old and 1 to 4 years old to be diagnosed with KS, a finding
which corresponds with the academic evidence (Burns et al. 1984; Gersony 1991; Chang
2003; Holman et al. 2003; Newburger et al. 2004; Kao 2005; Burns 2007;).
Texas has an access to care crisis that disproportionately and adversely affects
minorities’ children (Angel, Lein and Henrici 2006). Results of this study suggest that for the
Hispanic population, the most frequent source of admission came from physician referrals
(45.6%) in contrast to 36.2% of NHB and 53.3% of NHW. The utilization of ERs by NHB
was the highest among subgroups (51.7%). On the other hand, Hispanic utilization of
Medicaid was higher at 67.2 %, followed by NHB with 53.4% in contrast to 20% of NHW. In
particular, our findings highlight the healthcare disparities of the NHB group, more so than
expected. Healthcare providers, in particular primary care and ER providers, must be educated
and enables to be highly suspicious of KS in young children, in particular in API and NHB
children, presenting with fever and rash illnesses (Anderson, Todd and Glode 2005).
Only 49.4% of the patients in our sample were correctly diagnosed with KS upon
admission to a hospital. Remarkably, the API group was diagnosed in only 22.2% of the cases.
With less than 50% of the cases being diagnosed upon admission, we remain deeply
concerned with the data revealing 41 different admitting diagnoses other than KS. Given KS’
long-term health impact and relative obscurity, a pediatric infectious disease research priority
for finding its cause and another for educating providers and the direct community must be
developed. Identification of the causative agent(s) would be a promising step toward

developing a diagnostic test and ultimately preventing the disease (Rowley 2006). Meanwhile,
KS cases reported annually to the voluntary, “passive surveillance system” at the CDC
represented only about 10% of cases diagnosed with KS in the U.S. (Belay et al. 2003). A
national “active surveillance system” for KS will facilitate the monitoring of possible
nationwide or regional outbreaks and trends in coronary artery abnormalities resulting from
KS. Active surveillance may enable better quality of life and potentially increase years of life
for KS patients.
This is the first report of Kawasaki Syndrome in Texas since the 1984 Rauch et al.
study. Results of this study suggest there is a higher incidence rate based on using
hospitalization rate as a proxy than that reported by Rauch et al. for Harris County (Houston,
Texas) with 18.8% of all cases and a hospitalization rate of 15.7 per 100,000 children (Lloyd
et al. 2001). Rauch et al. reported 61 cases over 3 consecutive years, 1982 to 1984, recording
an incidence rate of 9.1 per 100,000 children of less than five years old and using a case
control study.
It is compelling that Collin County in DFW has the highest hospitalization rate at 29.1
per 100,000 children who are less than five years of age and at 30.6 per 100,000 children who
are less than 1 year old. The racial makeup of Collin County in 2006 included 9.7% of API
which might explain this observation (U.S. Census 2008). Our finding that 26.6% of all Texas
KS cases are distributed in the cluster of counties composing DFW produces great concern.
The current body of evidence does not explain this disproportionate incidence.
Limitations
The number of KS-associated hospitalizations might have been overestimated as
multiple KS hospitalizations for single cases were not screened. Inversely, many KS cases

could be missing from database because the disease could have been treated on an outpatient
basis, since not all children diagnosed with KS required hospitalization. Many KS patients
could have seen by health care providers in urgent care, outpatient, and family care settings
and as classical cases or incomplete or atypical KS cases (Newburger et al. 2004). Further,
contributing to the possible underestimates of KS cases, THCIC does not collect data from
rural hospitals with less than 100 beds.

CONCLUSION
The epidemiological trend of KS in Texas is consistent with national incidence rates.
The high incidence of KS in Non-Hispanic Black children (second only to API) is a source of
concern, especially since they experience disparities with significant healthcare access
problems. No significant difference was found between Hispanic and NHW children in ER
use for KS.
In Texas, healthcare providers clearly do not have enough experience or training with
KS to adequately identify and treat this disease. The disease appears more frequently in Texas’
DFW counties. The disease is not monitored by reporting agencies in Texas. No statewide
database is maintained, and an accurate numbers of KS cases are not collected annually by any
agency. Support must be established to mandate KS as reportable condition by hospitals.
Subsequently, such a mandate will establish a statewide, if not national, database for a disease
that clearly has significant public health ramifications. With the misdiagnosis rate more than
50%, educating physicians and other healthcare providers to recognize of the symptoms of KS
is imperative, particularly for ER and primary care providers.
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Table 1: Kawasaki Syndrome Associated Hospitalization Rates by Age,
Gender and Race/Ethnicity in Texas, 2004

Total
Years of age

Gender
Children <1
year by race/
ethnicity

children <5
year by race/
ethnicity

Age group by
gender

N=330

%

Hospitalization
rate*

Texas
Population
by age
groups

<1 year
1-4 year
5-9 year
10-14 year
15-17 year

44
203
62
11
4

13.3
61.5
18.8
3.3
1.2

11.7
14.3
3.8
0.6
0.4

375385
1417965
1620238
1730425
1028611

< 5 year
>5 year

247
83

74.8
25.2

13.8**
1.8

914552
878798

males
females

198
132

60
40

Hispanics
NHW
NHB

23
7
6

52.3
15.9
13.6

12.5
8.8
14.7**

183899
136545
40847

API

5

11.4

44.9**

11139

Hispanics
NHW
NHB
API

107
66
37
16

43.3
26.7
15
6.5

12.6
9.7
18.4**
29.8**

847501
680207
201470
53731

Male
<1
1-4

29
117

65.9
57.6

15.1**
16.2

191467
723085

Female
<1
1-4

14
86

34.1
42.4

8.2
12.4

183918
694880

Age group

Age group by
gender

* Per 100,000 children * * p<0.05. NHW= Non-Hispanic Whites; NHB= NonHispanic Blacks; API= Asians and Pacific Islander
Source: Texas Health Care Information Collection (THCIC) and Texas State Data
Center for 2004.

Table 2: Risk Mortality, Illness Severity, Admitting Diagnosis, Source of Admission and
Payment Source by Race/Ethnicity in Texas, 2004

Risk Mortality

Minor
Moderate
Major/ Extreme

Total N
(% based on
330)
N %
311 (94.2)
13 (3.9)
6 (1.8)

NHB
(% based on
58)
N %
51 (87.9)
4 (6.9)
3 (5.2)

Hispanics
(% based on
125)
N %
120 (96.0)
3 (2.4)
2 (1.6)

NHW
(% based on
105)
N %
100 (95.2)
4 (3.8)
1 (1.0)

API
(% based
on 18)
N %
17 (94.4)
1 (5.6)
0 (0)

Minor
Moderate
Major/ Extreme

240 (72.7)
72 (21.8)
18 (5.5)

36 (62.1)
16 (27.6)
6(10.3)

90 (72.0)
30 (24.0)
5 (4.0)

80 (76.2)
19 (18.1)
6 (5.7)

16 (88.9)
1(5.6)
1 (5.6)

Kawasaki
Syndrome

163 (49.4)

34 (58.6)

63 (50.4)

54 (51.4)

4 (22.2)

Fever
Rash/Nonspecific
Skin Eruption

107 (32.4)
19 (5.8)

15 (25.9)
1(1.7)

36 (28.8)
6 (4.8)

33 (31.4)
10 (9.5)

13 (72.2)
1 (5.6)

Other diagnosis

41 (12.4)

8 (13.8)

20 (16.0)

8 (7.7)

0 (0)

Physician
Referral

161 (48.8)

21 (36.2)

57 (45.6)

56 (53.3)

10 (55.6)

ER
Transfer from
Hospital

131 (39.7)
25 (7.6)

30 (51.7)
4 (6.9)

52 (41.6)
10 (8.0)

35 (33.3)
11 (10.5)

8 (44.4)
0 (0)

13 (3.9)

3 (5.2)

6 (4.8)

3 (2.9)

0(0)

155 (47.0)
149 (45.2)
19 (5.8)

21 (36.2)
31 (53.4)
4 (6.9)

35 (28.0)
84 (67.2)
4 (3.2)

76 (72.4)
21 (20.0)
5 (4.8)

9 (50)
5 (27.8)
4 (22.2)

7 (2.1)

2 (3.4)

2 (1.6)

3 (2.9)

0 (0)

Illness Severity

Admitting
Diagnosis

Source of
Admission

Other
Payment Source

Private
Medicaid
Self-pay/Indigent
Other

NHW= Non-Hispanic Whites; NHB= Non-Hispanic Blacks; API= Asians and Pacific Islander
Source: Texas Health Care Information Collection (THCIC) for 2004.
Note: “Private” included any patient who had insurance whether HMO, PPO, CHAMPUS, Blue
Cross/Blue Shield, or Commercial Insurance.

Table 3: Texas Counties with More Than 4% of Kawasaki Syndrome Cases in 2004

County

Total
Cases

%

Population
<18 Years

Hospitalization
rate
Per 100,000
<18 Years

Collin
17
5.2
177719
13.1
Hidalgo 19
6.1
227814
12.2
Travis
13
4.2
206848
9.4
Harris
61
18.8 1028371
8.5
Dallas
36
11.5 640376
8.2
Bexar
16
4.8
410504
5.5
Tarrant 16
4.8
444525
5.1
* As there was no new born with KS in Bexar in 2004

Population
<5 Years

Hospitalization
rate
Per 100,000
<5 Years

Population
<1 Year

Hospitalization
rate
Per 100,000
<1 Year

48176
72314
68233
312370
199154
120029
130774

29.0
18
17.6
15.7
16.1
11.7
7.7

9807
15977
14287
66148
41548
24970
27172

30.6
6.3
42.0
10.6
12.0
0*
14.7

